LONDON, February 5, 2025 (ITIA Press Release)

The International Tennis Integrity Agency (ITIA) today confirms that Gonçalo Oliveira, a 29-year-old Portuguese-born tennis player who currently represents Venezuela, has been provisionally suspended under the Tennis Anti-Doping Programme (TADP).

The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 17 January 2025 under Article 2.1 of the TADP (presence of a Prohibited Substance in a Player’s Sample) and/or Article 2.2 (Use of a Prohibited Substance without a valid Therapeutic Use Exemption (TUE)).

Oliveira, who reached a career-high world doubles ranking of 77 in August 2020, provided an in-competition sample while competing in an ATP Challenger event in Manzanillo, Mexico, on 25 November 2024.

The sample was split into A and B samples and the subsequent analysis found that the A sample contained metamfetamine, which is prohibited under the TADP, in the category of Stimulants (section S6.A of the 2024 World Anti-Doping Agency Prohibited List).

Metamfetamine is a non-Specified Substance, and Oliveira did not possess a valid TUE for the substance.

Findings for non-Specified Substances carry a mandatory provisional suspension – in Oliveira’s case, this has been in effect from 17 January 2025. Players have the right to appeal the imposition of their provisional suspension before an independent tribunal chair. Oliveira has not appealed.

While provisionally suspended, Oliveira is prohibited from playing in, coaching at, or attending any tennis event authorised or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.